AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
CABOTEGRAVIR SODIUM in Zambia
2 products registered with ZAMRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| APRETUDE 30mg Tablet, Filmcoated | ZAMRA-HM-23-61 | GlaxoSmithKline South Africa (Pty) Ltd | active | 6 Sept 2028 |
| APRETUDE 600mg/3ml Suspension for Injection | ZAMRA-HM-23-62 | GlaxoSmithKline South Africa (Pty) Ltd | active | 6 Sept 2028 |
CABOTEGRAVIR SODIUM — ZAMRA Registration Details
ZAMRA (Zambia) has 2 registered products containing CABOTEGRAVIR SODIUM, of which 2 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track CABOTEGRAVIR SODIUM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.